Further studies are needed to investigate how the H1047R mutation in p110α causes the downregulation of Bcl-2 and to understand the role of Bcl-2 and PIP3 in the H1047R mutation-mediated CRC metastasis. This evidence concerns the gene BCL2 and colorectal carcinoma.